Which of these blue chip giants is a more compelling investment right now?Constellation Brands (STZ 0.09%) and Altria (MO -1.30%) are both often considered stable blue chip stocks for income investors. Constellation is one of the world's largest producers of beers, wines, and spirits, while Altria is the largest tobacco company in America.Over the past three years, however, Constellation's stock stumbled nearly 30% as Altria's stock rallied more than 40%. Let's see why the tobacco maker outperformed the alc ...

Key Takeaways MO's Q1 2025 pricing strategy drove revenue gains across the Smokeable and Oral Tobacco segments. Strong pricing power helped MO maintain margins despite cigarette volume declines and regulations. MO expects 2025 EPS of $5.30-$5.45, reflecting up to 5% growth from 2024's adjusted base of $5.19.Altria Group, Inc. (MO) has demonstrated remarkable resilience in a challenging operating environment, and a major driver of this strength is its robust pricing strategy. Despite ongoing volume pressur ...

Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Altria (MO) , which belongs to the Zacks Tobacco industry.This owner of Philip Morris USA, the nation's largest cigarette maker has seen a nice streak of beating earnings estimates, especially when looking at the previous two reports. The average surprise for the last two quarters was 3.35%.For the last reported quarter, Altria came out with earnings of $1.23 ...

I am focused on growth and dividend income. My personal strategy revolves around setting myself up for an easy retirement by creating a portfolio which focuses on compounding dividend income and growth. Dividends are an intricate part of my strategy as I have structured my portfolio to have monthly dividend income which grows through dividend reinvestment and yearly increases. Feel free to reach out to me on Seeking Alpha Disclaimer: I am not an investment advisor or professional. This article is my own per ...

股价表现 - Altria Group股价在周三交易中大幅下跌4.1%，盘中最大跌幅达4.5%，而同期标普500指数上涨0.3% [1] - 过去一年公司股价累计上涨约24%，但Jefferies发布看空评级后引发抛售 [1][3] 分析师评级 - Jefferies首次覆盖Altria股票并给予"逊于大盘"评级，设定12个月目标价50美元，隐含12.5%下跌空间 [3] - 分析师认为近期股价上涨使估值偏高，当前市盈率约为10.6倍预期收益 [5] 业务现状 - 传统烟草产品面临结构性衰退，近年卷烟销量持续下滑，公司通过提价抵消销量下降影响 [4] - 公司正推动无烟产品发展并取得进展，但能否完全抵消卷烟销售下滑尚待观察 [5] 财务指标 - 公司股息收益率约为7.2%，在当前估值水平下未出现明显高估迹象 [5]

股价表现 - 奥驰亚集团(MO)过去6个月上涨21.2%，超越必需消费品板块(10.7%)和标普500指数(6.3%)，但落后于烟草行业整体涨幅(40.8%) [1] - 菲利普莫里斯国际(PM)同期上涨51.2%，Turning Point Brands(TPB)上涨28.5%，英美烟草(BTI)上涨37% [3] - 当前股价60.25美元接近52周高点61.26美元(差距1.6%)，且位于50日均线(58.53美元)和200日均线(53.54美元)上方 [4][5] 业务驱动因素 - 核心品牌万宝路在高端香烟市场份额提升至59.3%，第一季度实现10.8%净价格增长，推动调整后运营收入增长2.7% [8][9] - 无烟产品中on!口含尼古丁袋出货量增长18%，占口含烟草市场份额8.8%，占尼古丁袋细分市场17.9% [10] - 电子烟业务因NJOY ACE产品暂时退出市场受阻，但公司正改进产品线准备重新进入，目前美国市场60%被非法电子烟占据 [11] 股东回报 - 第一季度回购570万股股票(3.26亿美元)，支付股息17亿美元 [6][12] 估值水平 - 当前12个月前瞻市盈率11.03，低于行业平均15.28，显著低于PM(22.88)和TPB(20.03)，略高于BTI(10.41) [13][15] - 价值评分B级，显示相对于市场具有吸引力估值 [15]

公司特点 - 公司股票以安全性著称 常被描述为"夜夜安枕"的投资标的 [1] - 股息增长稳定 被比作"钟表般精准" 适合股息增长投资(DGI)和股息再投资计划(DRIP)策略 [1] - 兼具合理价格成长(GARP)特性 适合长期价值投资者 [1] 投资属性 - 长期投资可配置"严肃资金" 短期交易可视为"娱乐资金" [1] - 分析师持有该公司多头仓位 包括股票、期权或其他衍生品 [2]

One and half years after my last coverage of Altria Group, Inc. (NYSE: MO ) I can say with confidence my bearish call was plain wrong.I’m a Financial Analyst at a Fortune 500 company, investing with a long runway—30 years to retirement and plenty of compounding ahead. I write about building a thoughtful portfolio that balances strong growth potential with solid fundamentals. My focus is on high-quality businesses, mostly in the U.S. and Europe—companies with staying power, industry-leading profitability, lo ...

公司业绩与战略 - Altria集团旗下无烟产品品牌on!在2025年第一季度表现强劲 出货量增长超过18% 同时其口含烟草市场份额提升至8.8% 同比上升1.8个百分点 [1] - on!品牌在尼古丁袋细分市场的份额达到17.9% 显示出品牌在价格上涨情况下的竞争力 [1] - 公司计划推出新产品on! PLUS 针对成年口含烟草用户 以扩大市场份额 [2] 市场推广与品牌建设 - Altria通过"It's On!"营销活动显著提升品牌认知度 消费者印象增长近五倍 尼古丁袋用户的品牌认知度超过60% [2] - 公司凭借深厚的零售关系和营销灵活性 有望持续推动销量增长 [3] 行业竞争格局 - 菲利普莫里斯(PM)旗下品牌ZYN在尼古丁袋市场占据主导地位 2025年第一季度出货量同比增长63% 达到2亿罐以上 [4] - Turning Point Brands(TPB)通过FRE和ALP品牌实现快速增长 预计全年尼古丁袋收入将实现近10倍同比增长 并扩大销售团队和零售合作 [5] 股价表现与估值 - Altria股价在过去一个月上涨1.5% 跑赢行业平均下跌0.2%的表现 [6] - 公司远期市盈率为10.84倍 低于行业平均的15.11倍 [8] 盈利预测 - Zacks对Altria 2025年和2026年盈利的共识预期分别为同比增长4.9%和3.3% [9] - 2025年第二季度盈利预期为1.36美元 第三季度为1.44美元 全年为5.37美元 2026年全年为5.55美元 [10]

核心观点 - Altria股票的核心吸引力在于其高达6 9%的股息收益率 远高于标普500平均1 3%和必需消费品行业平均2 5%的水平 [1] - 但公司面临香烟销量持续下滑(2025年一季度同比下降13 7%)和替代产品转型失败的双重压力 长期股息可持续性存疑 [4][9] 业务构成 - 公司主营尼古丁产品 香烟占据收入绝大部分 因产品成瘾性被归类为必需消费品行业 [2] - 必需消费品通常需求稳定 但香烟近年需求可靠性下降 行业属性与产品风险形成矛盾 [4] 经营挑战 - 香烟销量呈现长期下滑趋势 2025年一季度同比降幅达13 7% 且为持续性而非单次事件 [4] - 公司三次转型尝试均告失败：NJOY产品因专利诉讼导致9亿美元减值 Juul投资因监管问题减值数十亿美元 Cronos大麻投资最终放弃并计提减值 [6][7][8] 投资逻辑 - 高股息收益率(6 9%)表面吸引力与业务基本面持续恶化形成强烈反差 [1][10] - 长期投资者实质是在押注公司能成功找到香烟替代品 但管理层过往执行记录堪忧 [5][9] - 多数投资者可能需权衡高股息与业务不可持续之间的风险收益比 [10]